Tionlab Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $4.27M

  • Investors
  • 12

Tionlab Therapeutics General Information

Description

Developer of a drug delivery system designed for patients suffering from diabetes and cancer. The company develops injections that can be used to deliver drugs with the frequency of one injection per month, enabling healthcare companies to provide patients with a convenient way to consume medicines for various diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1910, U-TOWER, 120, Heungdeokjungang-ro
  • Giheung-gu
  • Yongin, Gyeonggi 16950
  • South Korea
+82
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 1910, U-TOWER, 120, Heungdeokjungang-ro
  • Giheung-gu
  • Yongin, Gyeonggi 16950
  • South Korea
+82

Tionlab Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tionlab Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series A) 31-Aug-2026 $4.27M Completed Pre-Clinical Trials
9. Accelerator/Incubator Completed Generating Revenue
8. Accelerator/Incubator Completed Generating Revenue
7. Accelerator/Incubator 20-Jul-2023 Completed Generating Revenue
6. Accelerator/Incubator 04-Jun-2022 Completed Generating Revenue
5. Accelerator/Incubator 01-Jun-2022 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
2. Seed Round 26-Jul-2021 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Tionlab Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Tionlab Therapeutics Patents

Tionlab Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025165146-A1 Depot composition with controlled initial release through hydrophobic ion pairing gelation for treatment of obesity and diabetes for providing improved medical therapy of semaglutide or tirzepatide, and method for preparing same Pending 29-Jan-2024
WO-2025150966-A1 Sustained-release lipid pre-concentrate comprising sorbitan saturated fatty acid and method for preparing same Inactive 12-Jan-2024
EP-4470524-A1 Lipid fusion depot composition with controlled initial release, and method for preparing same Pending 27-Jan-2022
EP-4470524-A4 Lipid fusion depot composition with controlled initial release, and method for preparing same Pending 27-Jan-2022
US-20260041636-A1 Lipid fusion depot composition with controlled initial release, and method for preparing same Pending 27-Jan-2022 A61K9/1271
To view Tionlab Therapeutics’s complete patent history, request access »

Tionlab Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tionlab Therapeutics Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Series Ventures Venture Capital Minority
Glitchor Partners Accelerator/Incubator Minority
Tech Incubator Program for Startup Accelerator/Incubator Minority
Korea Credit Guarantee Fund Venture Capital Minority
Shinhan Square Bridge Accelerator/Incubator
You’re viewing 5 of 12 investors. Get the full list »

Tionlab Therapeutics FAQs

  • When was Tionlab Therapeutics founded?

    Tionlab Therapeutics was founded in 2021.

  • Where is Tionlab Therapeutics headquartered?

    Tionlab Therapeutics is headquartered in Yongin, South Korea.

  • What is the size of Tionlab Therapeutics?

    Tionlab Therapeutics has 10 total employees.

  • What industry is Tionlab Therapeutics in?

    Tionlab Therapeutics’s primary industry is Drug Delivery.

  • Is Tionlab Therapeutics a private or public company?

    Tionlab Therapeutics is a Private company.

  • What is Tionlab Therapeutics’s current revenue?

    The current revenue for Tionlab Therapeutics is .

  • How much funding has Tionlab Therapeutics raised over time?

    Tionlab Therapeutics has raised $4.27M.

  • Who are Tionlab Therapeutics’s investors?

    Series Ventures, Glitchor Partners, Tech Incubator Program for Startup, Korea Credit Guarantee Fund, and Shinhan Square Bridge are 5 of 12 investors who have invested in Tionlab Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process